SMMT EPS Estimates
Summit Therapeutics Inc.
$15.28
+$0.15(+0.99%)
49
Overall
40
Value
66
Tech
42
Quality
Market Cap
$12.10B
Volume
1.58M
52W Range
$12.07 - $29.23
Target Price
$29.06
SMMT EPS estimates: the consensus estimate for Summit Therapeutics Inc.'s current fiscal year is -$1.20 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
SMMT EPS Estimates
- EPS estimate, current quarter
- $-0.28
- EPS estimate, next quarter
- $-0.40
- EPS estimate, current year
- $-1.20
- EPS estimate, next year
- $-1.25
- EPS growth, 3-year
- +31.39%
| Fiscal year | EPS |
|---|---|
| 2024 | $-0.31 |
| 2023 | $-0.99 |
| 2022 | $-0.41 |
| 2021 | $-0.96 |
| 2020 | $-0.76 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SMMT | $15.28 | +1.0% | 1.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Summit Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW